Unknown

Dataset Information

0

GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.

ABSTRACT:

SUBMITTER: Sievers P 

PROVIDER: S-EPMC8568855 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma.
| S-EPMC6295214 | biostudies-literature
Unknown Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.
| S-EPMC4234119 | biostudies-other
Unknown Fusions involving BCOR and CREBBP are rare events in infiltrating glioma.
| S-EPMC7271411 | biostudies-literature
Unknown Correlating ROS1 Protein Expression With <i>ROS1</i> Fusions, Amplifications, and Mutations.
| S-EPMC8474213 | biostudies-literature
Unknown Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer.
| S-EPMC3431177 | biostudies-literature
Unknown Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
| S-EPMC4465992 | biostudies-literature
Unknown <i>ALK</i> Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.
| S-EPMC5728036 | biostudies-literature
Unknown NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.
| S-EPMC7037946 | biostudies-literature
Unknown Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.
| S-EPMC4384213 | biostudies-literature
Unknown Rare Incidence of ROS1 Rearrangement in Cholangiocarcinoma.
| S-EPMC5266400 | biostudies-literature